The role of microRNAs in the pathogenesis of autoimmune diseases

Autoimmunity Reviews

Volumn 15, Issue 12, 2016, Pages 1171-1180

  Chen, Ji Qing ^a   Papp, Gábor ^a   Szodoray, Péter ^b   Zeher, Margit ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

MicroRNAs (miRs); Multiple sclerosis (MS); Primary Sj gren's syndrome (SS); Psoriasis; Rheumatoid arthritis (RA); Systemic lupus erythematosus (SLE); Systemic sclerosis (SSc)

Indexed keywords

MICRORNA;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; HUMAN; INNATE IMMUNITY; MULTIPLE SCLEROSIS; PATHOGENESIS; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; AUTOIMMUNE DISEASES; GENETICS; IMMUNOLOGY;

AUTOIMMUNE DISEASES; HUMANS; MICRORNAS;

EID: 84995678205     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.09.003     Document Type: Review

References (123)

1. [1] Chua, J.H., Armugam, A., Jeyaseelan, K., MicroRNAs: biogenesis, function and applications. Curr Opin Mol Ther 11 (2009), 189–199.
2. [2] Bartel, D.P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004), 281–297.
3. [3] Wang, H., Peng, W., Ouyang, X., Li, W., Dai, Y., Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res 160 (2012), 198–206, 10.1016/j.trsl.2012.04.002.
4. [4] Kapsogeorgou, E.K., Gourzi, V.C., Manoussakis, M.N., Moutsopoulos, H.M., Tzioufas, A.G., Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression. J Autoimmun 37 (2011), 129–135, 10.1016/j.jaut.2011.05.003.
5. [5] Furer, V., Greenberg, J.D., Attur, M., Abramson, S.B., Pillinger, M.H., The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol 136 (2010), 1–15, 10.1016/j.clim.2010.02.005.
6. [6] Lee, Y., Kim, M., Han, J., Yeom, K.-H., Lee, S., Baek, S.H., et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23 (2004), 4051–4060, 10.1038/sj.emboj.7600385.
7. [7] Cullen, B.R., Transcription and processing of human microRNA precursors. Mol Cell 16 (2004), 861–865, 10.1016/j.molcel.2004.12.002.
8. [8] Cai, X., Hagedorn, C.H., Cullen, B.R., Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10 (2004), 1957–1966, 10.1261/rna.7135204.
9. [9] Gregory, R.I., Yan, K.-P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., et al. The microprocessor complex mediates the genesis of microRNAs. Nature 432 (2004), 235–240, 10.1038/nature03120.
10. [10] Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425 (2003), 415–419, 10.1038/nature01957.
11. [11] Yi, R., Qin, Y., Macara, I.G., Cullen, B.R., Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17 (2003), 3011–3016, 10.1101/gad.1158803.
12. [12] Ruby, J.G., Jan, C.H., Bartel, D.P., Intronic microRNA precursors that bypass Drosha processing. Nature 448 (2007), 83–86, 10.1038/nature05983.
13. [13] Okamura, K., Hagen, J.W., Duan, H., Tyler, D.M., Lai, E.C., The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 130 (2007), 89–100, 10.1016/j.cell.2007.06.028.
14. [14] Berezikov, E., Chung, W.-J., Willis, J., Cuppen, E., Lai, E.C., Mammalian mirtron genes. Mol Cell 28 (2007), 328–336, 10.1016/j.molcel.2007.09.028.
15. [15] Park, J.-E., Heo, I., Tian, Y., Simanshu, D.K., Chang, H., Jee, D., et al. Dicer recognizes the 5′ end of RNA for efficient and accurate processing. Nature 475 (2011), 201–205, 10.1038/nature10198.
16. [16] Lund, E., Dahlberg, J.E., Substrate selectivity of exportin 5 and Dicer in the biogenesis of microRNAs. Cold Spring Harb Symp Quant Biol 71 (2006), 59–66, 10.1101/sqb.2006.71.050.
17. [17] Yoda, M., Cifuentes, D., Izumi, N., Sakaguchi, Y., Suzuki, T., Giraldez, A.J., et al. Poly(A)-specific ribonuclease mediates 3′-end trimming of Argonaute2-cleaved precursor microRNAs. Cell Rep 5 (2013), 715–726, 10.1016/j.celrep.2013.09.029.
18. [18] Fabian, M.R., Sonenberg, N., Filipowicz, W., Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79 (2010), 351–379, 10.1146/annurev-biochem-060308-103103.
19. [19] Lewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005), 15–20, 10.1016/j.cell.2004.12.035.
20. [20] Carthew, R.W., Sontheimer, E.J., Origins and mechanisms of miRNAs and siRNAs. Cell 136 (2009), 642–655, 10.1016/j.cell.2009.01.035.
21. [21] Valencia-Sanchez, M.A., Liu, J., Hannon, G.J., Parker, R., Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20 (2006), 515–524, 10.1101/gad.1399806.
22. [22] Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., Tuschl, T., Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 15 (2004), 185–197, 10.1016/j.molcel.2004.07.007.
23. [23] Pillai, R.S., Bhattacharyya, S.N., Filipowicz, W., Repression of protein synthesis by miRNAs: how many mechanisms?. Trends Cell Biol 17 (2007), 118–126, 10.1016/j.tcb.2006.12.007.
24. [24] Bruno, I., Wilkinson, M.F., P-bodies react to stress and nonsense. Cell 125 (2006), 1036–1038, 10.1016/j.cell.2006.06.003.
25. [25] Dai, R., Ahmed, S.A., MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res 157 (2011), 163–179, 10.1016/j.trsl.2011.01.007.
26. [26] Gangaraju, V.K., Lin, H., MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 10 (2009), 116–125, 10.1038/nrm2621.
27. [27] Chen, C.-Z., Li, L., Lodish, H.F., Bartel, D.P., MicroRNAs modulate hematopoietic lineage differentiation. Science 303 (2004), 83–86, 10.1126/science.1091903.
28. [28] Raghuwanshi, S., Karnati, H.K., Sarvothaman, S., Gutti, U., Saladi, R.G.V., Tummala, P.R., et al. microRNAs: key players in hematopoiesis. Adv Exp Med Biol 887 (2015), 171–211, 10.1007/978-3-319-22380-3_10.
29. [29] Akira, S., Uematsu, S., Takeuchi, O., Pathogen recognition and innate immunity. Cell 124 (2006), 783–801, 10.1016/j.cell.2006.02.015.
30. [30] Santegoets, K.C.M., van Bon, L., van den Berg, W.B., Wenink, M.H., Radstake, T.R.D.J., Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs?. FEBS Lett 585 (2011), 3660–3666, 10.1016/j.febslet.2011.04.028.
31. [31] Mogensen, T.H., Paludan, S.R., Reading the viral signature by Toll-like receptors and other pattern recognition receptors. J Mol Med (Berl) 83 (2005), 180–192, 10.1007/s00109-004-0620-6.
32. [32] Kawai, T., Akira, S., Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34 (2011), 637–650, 10.1016/j.immuni.2011.05.006.
33. [33] Roach, J.C., Glusman, G., Rowen, L., Kaur, A., Purcell, M.K., Smith, K.D., et al. The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci U S A 102 (2005), 9577–9582, 10.1073/pnas.0502272102.
34. [34] Takeda, K., Akira, S., Toll-like receptors in innate immunity. Int Immunol 17 (2005), 1–14, 10.1093/intimm/dxh186.
35. [35] Chen, J.-Q., Szodoray, P., Zeher, M., Toll-like receptor pathways in autoimmune diseases. Clin Rev Allergy Immunol, 2015, 10.1007/s12016-015-8473-z.
36. [36] Taganov, K.D., Boldin, M.P., Chang, K.-J., Baltimore, D., NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103 (2006), 12481–12486, 10.1073/pnas.0605298103.
37. [37] Hou, J., Wang, P., Lin, L., Liu, X., Ma, F., An, H., et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 183 (2009), 2150–2158, 10.4049/jimmunol.0900707.
38. [38] Tili, E., Michaille, J.-J., Cimino, A., Costinean, S., Dumitru, C.D., Adair, B., et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179 (2007), 5082–5089.
39. [39] Liu, G., Friggeri, A., Yang, Y., Park, Y.-J., Tsuruta, Y., Abraham, E., miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci U S A 106 (2009), 15819–15824, 10.1073/pnas.0901216106.
40. [40] Au, K.Y., Pong, J.C.H., Ling, W.L., Li, J.C.B., MiR-1303 regulates mycobacteria induced autophagy by targeting Atg2B. PLoS One, 11, 2016, e0146770, 10.1371/journal.pone.0146770.
41. [41] Husakova, M., MicroRNAs in the key events of systemic lupus erythematosus pathogenesis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2016, 10.5507/bp.2016.004.
42. [42] Cobb, B.S., Nesterova, T.B., Thompson, E., Hertweck, A., O'Connor, E., Godwin, J., et al. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 201 (2005), 1367–1373, 10.1084/jem.20050572.
43. [43] Muljo, S.A., Ansel, K.M., Kanellopoulou, C., Livingston, D.M., Rao, A., Rajewsky, K., Aberrant T cell differentiation in the absence of Dicer. J Exp Med 202 (2005), 261–269, 10.1084/jem.20050678.
44. [44] Koralov, S.B., Muljo, S.A., Galler, G.R., Krek, A., Chakraborty, T., Kanellopoulou, C., et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132 (2008), 860–874, 10.1016/j.cell.2008.02.020.
45. [45] Honardoost, M.A., Kiani-Esfahani, A., Ghaedi, K., Etemadifar, M., Salehi, M., miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis. Gene 544 (2014), 128–133.
46. [46] O'Connell, R.M., Kahn, D., Gibson, W.S.J., Round, J.L., Scholz, R.L., Chaudhuri, A.A., et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33 (2010), 607–619, 10.1016/j.immuni.2010.09.009.
47. [47] Ceppi, M., Pereira, P.M., Dunand-Sauthier, I., Barras, E., Reith, W., Santos, M.A., et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci U S A 106 (2009), 2735–2740, 10.1073/pnas.0811073106.
48. [48] Lu, L.-F., Thai, T.-H., Calado, D.P., Chaudhry, A., Kubo, M., Tanaka, K., et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30 (2009), 80–91, 10.1016/j.immuni.2008.11.010.
49. [49] Lu, L.-F., Boldin, M.P., Chaudhry, A., Lin, L.-L., Taganov, K.D., Hanada, T., et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142 (2010), 914–929, 10.1016/j.cell.2010.08.012.
50. [50] de Yébenes, V.G., Belver, L., Pisano, D.G., González, S., Villasante, A., Croce, C., et al. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J Exp Med 205 (2008), 2199–2206, 10.1084/jem.20080579.
51. [51] Gonzalez-Martin, A., Adams, B.D., Lai, M., Shepherd, J., Salvador-Bernaldez, M., Salvador, J.M., et al. The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity. Nat Immunol 17 (2016), 433–440, 10.1038/ni.3385.
52. [52] Rothfield, N., Clinical aspects and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 1 (1989), 327–331.
53. [53] Liu, Y.-J., Fan, W.-J., Bai, J.-Z., microRNA-126 expression and its mechanism of action in patients with systemic lupus erythematosus. Eur Rev Med Pharmacol Sci 19 (2015), 3838–3842.
54. [54] Zhu, J., Huang, X., Su, G., Wang, L., Wu, F., Zhang, T., et al. High expression levels of microRNA-629, microRNA-525-5p and microRNA-516a-3p in paediatric systemic lupus erythematosus. Clin Rheumatol 33 (2014), 807–815, 10.1007/s10067-014-2583-5.
55. [55] Dai, Y., Huang, Y.-S., Tang, M., Lv, T.-Y., Hu, C.-X., Tan, Y.-H., et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16 (2007), 939–946, 10.1177/0961203307084158.
56. [56] Dai, Y., Sui, W., Lan, H., Yan, Q., Huang, H., Huang, Y., Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 29 (2009), 749–754, 10.1007/s00296-008-0758-6.
57. [57] Tang, Y., Luo, X., Cui, H., Ni, X., Yuan, M., Guo, Y., et al. MicroRNA-146 A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 60 (2009), 1065–1075, 10.1002/art.24436.
58. [58] Liu, F., Fan, H., Ren, D., Dong, G., Hu, E., Ji, J., et al. TLR9-induced miR-155 and Ets-1 decrease expression of CD1d on B cells in SLE. Eur J Immunol 45 (2015), 1934–1945, 10.1002/eji.201445286.
59. [59] Lashine, Y.A., Salah, S., Aboelenein, H.R., Abdelaziz, A.I., Correcting the expression of miRNA-155 represses PP2Ac and enhances the release of IL-2 in PBMCs of juvenile SLE patients. Lupus 24 (2015), 240–247, 10.1177/0961203314552117.
60. [60] Liu, D., Zhang, N., Zhang, J., Zhao, H., Wang, X., miR-410 suppresses the expression of interleukin-6 as well as renal fibrosis in the pathogenesis of lupus nephritis. Clin Exp Pharmacol Physiol 43 (2016), 616–625, 10.1111/1440-1681.12576.
61. [61] Coit, P., Dozmorov, M.G., Merrill, J.T., McCune, W.J., Maksimowicz-McKinnon, K., Wren, J.D., et al. Epigenetic reprogramming in naïve CD4 + T cells favoring T cell activation and non-Th1 effector T cell immune response as an early event in lupus flares. Arthritis Rheumatol, 2016, 10.1002/art.39720.
62. [62] Qingjuan, L., Xiaojuan, F., Wei, Z., Chao, W., Pengpeng, K., Hongbo, L., et al. miR-148a-3p overexpression contributes to glomerular cell proliferation by targeting PTEN in lupus nephritis. Am J Physiol Cell Physiol 310 (2016), C470–C478, 10.1152/ajpcell.00129.2015.
63. [63] Wang, W., Mou, S., Wang, L., Zhang, M., Shao, X., Fang, W., et al. Up-regulation of serum MiR-130b-3p level is associated with renal damage in early lupus nephritis. Sci Rep, 5, 2015, 12644, 10.1038/srep12644.
64. [64] Solé, C., Cortés-Hernández, J., Felip, M.L., Vidal, M., Ordi-Ros, J., miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. Nephrol Dial Transplant 30 (2015), 1488–1496, 10.1093/ndt/gfv128.
65. [65] Perez-Hernandez, J., Forner, M.J., Pinto, C., Chaves, F.J., Cortes, R., Redon, J., Increased urinary exosomal microRNAs in patients with systemic lupus erythematosus. PLoS One, 10, 2015, e0138618, 10.1371/journal.pone.0138618.
66. [66] Gysler, S.M., Mulla, M.J., Guerra, M., Brosens, J.J., Salmon, J.E., Chamley, L.W., et al. Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8. Mol Hum Reprod, 2016, 10.1093/molehr/gaw027.
67. [67] Zeher, M., Szodoray, P., Sjögren's syndrome and associated disorders. vol. Sjögren's Syndrome. 2009, Transworld Research Network, Kerala, India.
68. [68] Szanto, A., Szodoray, P., Kiss, E., Kapitany, A., Szegedi, G., Zeher, M., Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus. Hum Immunol 67 (2006), 924–930, 10.1016/j.humimm.2006.06.006.
69. [69] Gourzi, V.C., Kapsogeorgou, E.K., Kyriakidis, N.C., Tzioufas, A.G., Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome. Clin Exp Immunol 182 (2015), 14–22, 10.1111/cei.12664.
70. [70] Liang, C., Xiong, K., Szulwach, K.E., Zhang, Y., Wang, Z., Peng, J., et al. Sjogren syndrome antigen B (SSB)/La promotes global microRNA expression by binding microRNA precursors through stem-loop recognition. J Biol Chem 288 (2013), 723–736, 10.1074/jbc.M112.401323.
71. [71] Alevizos, I., Alexander, S., Turner, R.J., Illei, G.G., MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. Arthritis Rheum 63 (2011), 535–544, 10.1002/art.30131.
72. [72] Zilahi, E., Tarr, T., Papp, G., Griger, Z., Sipka, S., Zeher, M., Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome. Immunol Lett 141 (2012), 165–168, 10.1016/j.imlet.2011.09.006.
73. [73] Bhaumik, D., Scott, G.K., Schokrpur, S., Patil, C.K., Campisi, J., Benz, C.C., Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27 (2008), 5643–5647, 10.1038/onc.2008.171.
74. [74] Chen, J.-Q., Zilahi, E., Papp, G., Sipka, S., Zeher, M., Simultaneously increased expression of microRNA-155 and suppressor of cytokine signaling 1 (SOCS1) gene in the peripheral blood mononuclear cells of patients with primary Sjögren's syndrome. Int J Rheum Dis, 2015, 10.1111/1756-185X.12804.
75. [75] Pauley, K.M., Stewart, C.M., Gauna, A.E., Dupre, L.C., Kuklani, R., Chan, A.L., et al. Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity. Eur J Immunol 41 (2011), 2029–2039, 10.1002/eji.201040757.
76. [76] Shi, H., Zheng, L., Zhang, P., Yu, C., miR-146a and miR-155 expression in PBMCs from patients with Sjögren's syndrome. J Oral Pathol Med 43 (2014), 792–797, 10.1111/jop.12187.
77. [77] Peng, L., Ma, W., Yi, F., Yang, Y.-J., Lin, W., Chen, H., et al. MicroRNA profiling in Chinese patients with primary Sjögren syndrome reveals elevated miRNA-181a in peripheral blood mononuclear cells. J Rheumatol 41 (2014), 2208–2213, 10.3899/jrheum.131154.
78. [78] Williams, A.E.G., Choi, K., Chan, A.L., Lee, Y.J., Reeves, W.H., Bubb, M.R., et al. Sjögren's syndrome-associated microRNAs in CD14(+) monocytes unveils targeted TGFβ signaling. Arthritis Res Ther, 18, 2016, 95, 10.1186/s13075-016-0987-0.
79. [79] Gibofsky, A., Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 18 (2012), S295–S302.
80. [80] Mookherjee, N., El-Gabalawy, H.S., High degree of correlation between whole blood and PBMC expression levels of miR-155 and miR-146a in healthy controls and rheumatoid arthritis patients. J Immunol Methods 400–401 (2013), 106–110, 10.1016/j.jim.2013.10.001.
81. [81] Tang, X., Yin, K., Zhu, H., Tian, J., Shen, D., Yi, L., et al. Correlation between the expression of microRNA-301a-3p and the proportion of Th17 cells in patients with rheumatoid arthritis. Inflammation, 2016, 10.1007/s10753-016-0304-8.
82. [82] Filková, M., Aradi, B., Šenolt, L., Ospelt, C., Vettori, S., Mann, H., et al. Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Ann Rheum Dis 73 (2014), 1898–1904, 10.1136/annrheumdis-2012-202815.
83. [83] Murata, K., Yoshitomi, H., Tanida, S., Ishikawa, M., Nishitani, K., Ito, H., et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther, 12, 2010, R86, 10.1186/ar3013.
84. [84] Kriegsmann, M., Randau, T.M., Gravius, S., Lisenko, K., Altmann, C., Arens, N., et al. Expression of miR-146a, miR-155, and miR-223 in formalin-fixed paraffin-embedded synovial tissues of patients with rheumatoid arthritis and osteoarthritis. Virchows Arch, 2016, 10.1007/s00428-016-1939-4.
85. [85] Ruedel, A., Dietrich, P., Schubert, T., Hofmeister, S., Hellerbrand, C., Bosserhoff, A.-K., Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts. Int J Clin Exp Pathol 8 (2015), 4953–4962.
86. [86] Wang, L., Song, G., Zheng, Y., Wang, D., Dong, H., Pan, J., et al. miR-573 is a negative regulator in the pathogenesis of rheumatoid arthritis. Cell Mol Immunol, 2015, 10.1038/cmi.2015.63.
87. [87] Li, J., Wan, Y., Guo, Q., Zou, L., Zhang, J., Fang, Y., et al. Altered microRNA expression profile with miR-146a upregulation in CD4 + T cells from patients with rheumatoid arthritis. Arthritis Res Ther, 12, 2010, R81, 10.1186/ar3006.
88. [88] Ogando, J., Tardáguila, M., Díaz-Alderete, A., Usategui, A., Miranda-Ramos, V., Martínez-Herrera, D.J., et al. Notch-regulated miR-223 targets the aryl hydrocarbon receptor pathway and increases cytokine production in macrophages from rheumatoid arthritis patients. Sci Rep, 6, 2016, 20223, 10.1038/srep20223.
89. [89] Xiao, M., Ma, Y., Chen, X., Kuang, B., Single nucleotide polymorphism of miR-149 and susceptibility of rheumatoid arthritis. Zhong Nan Da Xue Xue Bao Yi Xue Ban 40 (2015), 495–498, 10.11817/j.issn.1672–7347.2015.05.006.
90. [90] Casale, R., Buonocore, M., Matucci-Cerinic, M., Systemic sclerosis (scleroderma): an integrated challenge in rehabilitation. Arch Phys Med Rehabil 78 (1997), 767–773.
91. [91] Chen, C., Wu, C.-Q., Zhang, Z.-Q., Yao, D.-K., Zhu, L., Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation. Exp Cell Res 317 (2011), 1714–1725, 10.1016/j.yexcr.2011.05.001.
92. [92] Venugopal, S.K., Jiang, J., Kim, T.-H., Li, Y., Wang, S.-S., Torok, N.J., et al. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 298 (2010), G101–G106, 10.1152/ajpgi.00220.2009.
93. [93] Guo, C.-J., Pan, Q., Li, D.-G., Sun, H., Liu, B.-W., miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J Hepatol 50 (2009), 766–778, 10.1016/j.jhep.2008.11.025.
94. [94] Freischmidt, A., Müller, K., Ludolph, A.C., Weishaupt, J.H., Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol Commun, 1, 2013, 42, 10.1186/2051-5960-1-42.
95. [95] Ji, J., Zhang, J., Huang, G., Qian, J., Wang, X., Mei, S., Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 583 (2009), 759–766, 10.1016/j.febslet.2009.01.034.
96. [96] Honda, N., Jinnin, M., Kira-Etoh, T., Makino, K., Kajihara, I., Makino, T., et al. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3. Am J Pathol 182 (2013), 206–216, 10.1016/j.ajpath.2012.09.023.
97. [97] Makino, K., Jinnin, M., Aoi, J., Hirano, A., Kajihara, I., Makino, T., et al. Discoidin domain receptor 2-microRNA 196a-mediated negative feedback against excess type I collagen expression is impaired in scleroderma dermal fibroblasts. J Invest Dermatol 133 (2013), 110–119, 10.1038/jid.2012.252.
98. [98] Honda, N., Jinnin, M., Kajihara, I., Makino, T., Makino, K., Masuguchi, S., et al. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts. J Immunol 188 (2012), 3323–3331, 10.4049/jimmunol.1100876.
99. [99] Makino, K., Jinnin, M., Kajihara, I., Honda, N., Sakai, K., Masuguchi, S., et al. Circulating miR-142-3p levels in patients with systemic sclerosis. Clin Exp Dermatol 37 (2012), 34–39, 10.1111/j.1365-2230.2011.04158.x.
100. [100] Sing, T., Jinnin, M., Yamane, K., Honda, N., Makino, K., Kajihara, I., et al. microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma. Rheumatology (Oxford) 51 (2012), 1550–1556, 10.1093/rheumatology/kes120.
101. [101] Zhu, H., Li, Y., Qu, S., Luo, H., Zhou, Y., Wang, Y., et al. MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma. J Clin Immunol 32 (2012), 514–522, 10.1007/s10875-011-9647-y.
102. [102] Shan, H., Zhang, Y., Lu, Y., Zhang, Y., Pan, Z., Cai, B., et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 83 (2009), 465–472, 10.1093/cvr/cvp130.
103. [103] Wang, B., Koh, P., Winbanks, C., Coughlan, M.T., McClelland, A., Watson, A., et al. miR-200a prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes 60 (2011), 280–287, 10.2337/db10-0892.
104. [104] Liu, G., Friggeri, A., Yang, Y., Milosevic, J., Ding, Q., Thannickal, V.J., et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207 (2010), 1589–1597, 10.1084/jem.20100035.
105. [105] Zhong, X., Chung, A.C.K., Chen, H.-Y., Meng, X.-M., Lan, H.Y., Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 22 (2011), 1668–1681, 10.1681/ASN.2010111168.
106. [106] Ciechomska, M., O'Reilly, S., Suwara, M., Bogunia-Kubik, K., van Laar, J.M., MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis. PLoS One, 9, 2014, e115596, 10.1371/journal.pone.0115596.
107. [107] Jafarinejad-Farsangi, S., Farazmand, A., Mahmoudi, M., Gharibdoost, F., Karimizadeh, E., Noorbakhsh, F., et al. MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis. Autoimmunity 48 (2015), 369–378, 10.3109/08916934.2015.1030616.
108. [108] O'Reilly, S., Ciechomska, M., Fullard, N., Przyborski, S., van Laar, J.M., IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics. Sci Rep, 6, 2016, 25066, 10.1038/srep25066.
109. [109] Iwamoto, N., Vettori, S., Maurer, B., Brock, M., Pachera, E., Jüngel, A., et al. Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression. Ann Rheum Dis 75 (2016), 303–310, 10.1136/annrheumdis-2014-205326.
110. [110] Polman, C.H., Reingold, S.C., Edan, G., Filippi, M., Hartung, H.-P., Kappos, L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.”. Ann Neurol 58 (2005), 840–846, 10.1002/ana.20703.
111. [111] Fenoglio, C., Cantoni, C., De Riz, M., Ridolfi, E., Cortini, F., Serpente, M., et al. Expression and genetic analysis of miRNAs involved in CD4 + cell activation in patients with multiple sclerosis. Neurosci Lett 504 (2011), 9–12, 10.1016/j.neulet.2011.08.021.
112. [112] Devier, D.J., Lovera, J.F., Lukiw, W.J., Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration. Front Mol Neurosci, 8, 2015, 5, 10.3389/fnmol.2015.00005.
113. [113] Du, C., Liu, C., Kang, J., Zhao, G., Ye, Z., Huang, S., et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 10 (2009), 1252–1259, 10.1038/ni.1798.
114. [114] Ahmadian-Elmi, M., Bidmeshki Pour, A., Naghavian, R., Ghaedi, K., Tanhaei, S., Izadi, T., et al. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4(+) T lymphocytes of patients with relapsing–remitting multiple sclerosis. Immunogenetics 68 (2016), 43–54, 10.1007/s00251-015-0881-y.
115. [115] Guan, H., Singh, U.P., Rao, R., Mrelashvili, D., Sen, S., Hao, H., et al. Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells. Immunology 147 (2016), 488–498, 10.1111/imm.12583.
116. [116] Mancuso, R., Hernis, A., Agostini, S., Rovaris, M., Caputo, D., Clerici, M., MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression. J Transl Med, 13, 2015, 148, 10.1186/s12967-015-0504-2.
117. [117] Bergman, P., Piket, E., Khademi, M., James, T., Brundin, L., Olsson, T., et al. Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis. Neurol Neuroimmunol Neuroinflammation, 3, 2016, e219, 10.1212/NXI.0000000000000219.
118. [118] Christophers, E., Psoriasis—epidemiology and clinical spectrum. Clin Exp Dermatol 26 (2001), 314–320.
119. [119] Løvendorf, M.B., Mitsui, H., Zibert, J.R., Røpke, M.A., Hafner, M., Dyring-Andersen, B., et al. Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis. Exp Dermatol 24 (2015), 187–193, 10.1111/exd.12604.
120. [120] Ele-Refaei, A.M., El-Esawy, F.M., Effect of narrow-band ultraviolet B phototherapy and methotrexate on microRNA (146a) levels in blood of psoriatic patients. Dermatol Res Pract, 2015, 2015, 145769, 10.1155/2015/145769.
121. [121] Tsuru, Y., Jinnin, M., Ichihara, A., Fujisawa, A., Moriya, C., Sakai, K., et al. miR-424 levels in hair shaft are increased in psoriatic patients. J Dermatol 41 (2014), 382–385, 10.1111/1346-8138.12460.
122. [122] Cheung, L., Fisher, R.M., Kuzmina, N., Li, D., Li, X., Werngren, O., et al. Psoriasis skin inflammation-induced microRNA-26b targets NCEH1 in underlying subcutaneous adipose tissue. J Invest Dermatol 136 (2016), 640–648, 10.1016/j.jid.2015.12.008.
123. [123] Zhang, W., Yi, X., Guo, S., Shi, Q., Wei, C., Li, X., et al. A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study. J Cell Mol Med 18 (2014), 2225–2234, 10.1111/jcmm.12359.